T1	p 51 82	adults with autistic disorder .
T2	p 233 272	adult patients with autistic disorder .
T3	p 281 352	Twenty drug-free adults with autistic disorder ( 16 men and 4 women ) (
T4	p 364 372	SD ] age
T5	p 375 395	30.5 +/- 8.5 years )
T6	p 936 966	17 patients who completed both
T7	p 1701 1708	who had
T8	p 2117 2139	patients with autism .
T9	p 2282 2297	some patients .
T10	p 2386 2403	autistic disorder
T11	i 458 476	placebo-controlled
T12	i 529 576	24-hour , low-tryptophan diet followed the next
T13	i 591 607	amino acid drink
T14	i 665 681	amino acid drink
T15	i 856 877	sham testing sessions
T16	i 1287 1359	flapping , pacing , banging and hitting self , rocking , and toe walking
T17	i 1500 1534	relatedness or repetitive thoughts
T18	i 1652 1689	tryptophan-deficient amino acid drink
T19	o 28 40	depletion in
T20	o 164 198	and biochemical responses to acute
T21	o 210 219	depletion
T22	o 428 437	depletion
T23	o 621 628	ratings
T24	o 752 784	free and total tryptophan levels
T25	o 1005 1028	worsening of behavioral
T26	o 1043 1053	short-term
T27	o 1065 1074	depletion
T28	o 1138 1153	clinical status
T29	o 1258 1267	behaviors
T30	o 1287 1361	flapping , pacing , banging and hitting self , rocking , and toe walking (
T31	o 1421 1425	calm
T32	o 1436 1439	and
T33	o 1445 1454	anxious .
T34	o 1470 1476	change
T35	o 1493 1589	social relatedness or repetitive thoughts and behavior . Plasma total and free tryptophan levels
T36	o 1730 1754	exacerbation of symptoms
T37	o 1780 1819	baseline plasma total tryptophan levels
T38	o 1837 1869	Autism Behavior Checklist scores
T39	o 1937 1951	symptoms after
T40	o 1973 1974	.
T41	o 2100 2108	function
T42	o 2245 2253	symptoms